Semaglutide

SEMAGLUTIDE is a synthetic peptide supplied by First Due Research as a lyophilized powder intended exclusively for laboratory research and analytical applications.

Each vial contains SEMAGLUTIDE in a dry, freeze-dried form. Lyophilization is employed to enhance stability during storage and handling by reducing residual moisture and supporting preservation of peptide structure under appropriate laboratory conditions.

From a molecular standpoint, SEMAGLUTIDE is a modified 31–amino acid peptide featuring specific amino acid substitutions and a site-specific acylation with a C18 fatty diacid via a spacer on a lysine residue. These defined structural modifications contribute to increased molecular stability and resistance to degradation in controlled experimental environments. The compound has an approximate molecular weight of 4,113.6 Da and is produced through controlled synthetic peptide manufacturing processes with a defined primary amino acid sequence.

In research settings, SEMAGLUTIDE is commonly characterized using analytical techniques such as high-performance liquid chromatography (HPLC), mass spectrometry, and related physicochemical methods to confirm identity, purity, and structural consistency.

This material is provided strictly for research purposes only. SEMAGLUTIDE is not intended for human or animal use and is not a drug, food, dietary supplement, or cosmetic. No claims are made regarding biological activity, safety, or efficacy. Handling and use are limited to qualified research professionals operating in controlled laboratory environments.